Cell Line Development Market Size to Expand with Rising Demand for Biologics Production
The Cell Line Development Market is closely linked to the growth of biopharmaceutical manufacturing, which relies heavily on stable and high-yield cell lines for the production of biologics. Valued at USD 6.17 billion in 2024 and projected to reach USD 15.43 billion by 2034, the market is expanding at a CAGR of 9.6%, reflecting the increasing demand for advanced therapeutic solutions....
0 Reacties 0 aandelen 134 Views 0 voorbeeld
Sponsor